InnAccel — Advancing Care from birth to breathThe Centre for Cellular and Molecular Platforms (C-CAMP)-supported startup InnAccel Technologies has built a portfolio of novel medical…Mar 5Mar 5
Why NGS is the next big step in the AMR battleSince their discovery, antimicrobials have revolutionised the treatment of infectious diseases. Their availability allows the existence of…Jun 5, 2024Jun 5, 2024
Role of registries in tackling the problem of AMR.A team led by Shraddha Karve of Ashoka University, India, won the Wellcome Trust award (1) to understand how the weather might impact…May 8, 2024May 8, 2024
Using direct-acting agents to target resistant bacteriaDirect acting agents with their coupling potential with novel delivery agents hold the key to developing next generation of antimicrobials.Nov 18, 2023Nov 18, 2023
Vaccines as key players in mitigating AMR (Part-III).-Vaccines, an oft-neglected strategy to reduce antibiotic usageOct 6, 2023Oct 6, 2023
Vaccines as key players in mitigating AMR (Part-II)Latest news on vaccine R&D against key bacterial pathogensAug 10, 2023Aug 10, 2023
A glimpse into the innovations on AMR Quest Winners list so farC-CAMP AMR Quest is a platform for AMR interventions from India that entered its 4th year in 2023.Jul 18, 2023Jul 18, 2023
The Gut-microbiome : a potential ally under siege from AMROne direct adverse effect of antibiotic use is the selection & spread of AMR genes in gut microbiota & evolution of microbiome therapeuticsJun 26, 2023Jun 26, 2023
